Symptom Profiles of a Convenience Sample of Patients with COVID-19 - United States, January-April 2020.


Journal

MMWR. Morbidity and mortality weekly report
ISSN: 1545-861X
Titre abrégé: MMWR Morb Mortal Wkly Rep
Pays: United States
ID NLM: 7802429

Informations de publication

Date de publication:
17 Jul 2020
Historique:
entrez: 17 7 2020
pubmed: 17 7 2020
medline: 18 7 2020
Statut: epublish

Résumé

Coronavirus disease 2019 (COVID-19) was first detected in the United States in January 2020 (1), and by mid-July, approximately 3.4 million cases had been reported in the United States (2). Information about symptoms among U.S. COVID-19 patients is limited, especially among nonhospitalized patients. To better understand symptom profiles of patients with laboratory-confirmed COVID-19 in the United States, CDC used an optional questionnaire to collect detailed information on a convenience sample of COVID-19 patients from participating states. Symptom data were analyzed by age group, sex, hospitalization status, and symptom onset date relative to expansion of testing guidelines on March 8, 2020 (3). Among 164 symptomatic patients with known onset during January 14-April 4, 2020, a total of 158 (96%) reported fever, cough, or shortness of breath. Among 57 hospitalized adult patients (aged ≥18 years), 39 (68%) reported all three of these symptoms, compared with 25 (31%) of the 81 nonhospitalized adult patients. Gastrointestinal (GI) symptoms and other symptoms, such as chills, myalgia, headache, and fatigue, also were commonly reported, especially after expansion of testing guidelines. To aid prompt recognition of COVID-19, clinicians and public health professionals should be aware that COVID-19 can cause a wide variety of symptoms.

Identifiants

pubmed: 32673296
doi: 10.15585/mmwr.mm6928a2
pmc: PMC7366851
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

904-908

Investigateurs

Neha Balachandran (N)
Rebecca M Dahl (RM)
Mary Dott (M)
Zunera Gilani (Z)
Aaron Grober (A)
Jessica Leung (J)
Michelle O'Hegarty (M)
John Person (J)
Jessica N Ricaldi (JN)
Nicole M Roth (NM)
James J Sejvar (JJ)
Tom Shimabukuro (T)
Cuc H Tran (CH)
John T Watson (JT)
Hilary Whitham (H)
Howard Chiou (H)
Paula Clogher (P)
Lindsey M Duca (LM)
Alissa Dratch (A)
Amanda Feldpausch (A)
Mary-Margaret Fill (MM)
Isaac Ghinai (I)
Michelle Holshue (M)
Sarah Scott (S)
Ryan Westergaard (R)

Déclaration de conflit d'intérêts

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Références

Clin Infect Dis. 2020 Jul 28;71(15):889-890
pubmed: 32215618
JAMA. 2020 Apr 22;:
pubmed: 32320008
N Engl J Med. 2020 Mar 5;382(10):929-936
pubmed: 32004427
Euro Surveill. 2020 Apr;25(16):
pubmed: 32347200
BMJ. 2020 May 22;369:m1985
pubmed: 32444460

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH